Maryam Nasirian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Maryam Nasirian has a total of 163 co-authors. Here are the top co-authors by number of shared publications:
- Ali Akbar Haghdoost
Kerman University of Medical Sciences
9 shared publications - Mohammad Reza Baneshi
Center for Longitudinal and Life Course Research, School of Public Health, The University of Queensland, Herston, Queensland, Australia
5 shared publications Setayesh Sindarreh
Cancer Prevention Research Center Isfahan University of Medical Sciences Isfahan Iran
5 shared publications- Mohammad Karamouzian
Centre on Drug Policy Evaluation, MAP Centre for Urban Health Solutions, St. Michael’s Hospital, Toronto, ON, Canada
4 shared publications Amirreza Manteghinejad
Cancer Prevention Research Center, Omid Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
3 shared publicationsForugh Aleebrahim
Health Faculty Student Research Committee Isfahan University of Medical Sciences Isfahan Iran
3 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by Termedia Sp. z.o.o. in HIV & AIDS Review
Comparison of social support and social network among people living with HIV and general population in Isfahan, Iran
Introduction: Social support is an important aspect of life of people living with human immunodeficiency virus (PLHIV), affecting their physical and mental health. Humans receive the most social support from their social networks, characterized as interpersonal social ties. This study aimed...
- 25 September 2026
- Published by Termedia Sp. z.o.o. in HIV & AIDS Review
Open AccessComparison of social support and social network among people living with HIV and general population in Isfahan, Iran
Introduction: Social support is an important aspect of life of people living with human immunodeficiency virus (PLHIV), affecting their physical and mental health. Humans receive the most social support from their social networks, characterized as interpersonal social ties. This study aimed...
- Open Access
- 25 September 2026
- Published by Termedia Sp. z.o.o. in HIV & AIDS Review
Investigating the status of HIV self-testing before and during the COVID-19 pandemic: a systematic review study
In order to effectively address the goals of human immunodeficiency virus (HIV) prevention and control on both regional and global scales, there is a pressing need for an innovative approach to providing testing-related services. The objective of this study was to scrutinize and compare the...
- 25 September 2026
- Published by Termedia Sp. z.o.o. in HIV & AIDS Review
Open AccessInvestigating the status of HIV self-testing before and during the COVID-19 pandemic: a systematic review study
In order to effectively address the goals of human immunodeficiency virus (HIV) prevention and control on both regional and global scales, there is a pressing need for an innovative approach to providing testing-related services. The objective of this study was to scrutinize and compare the...
- Open Access
- 25 July 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (8)
Risk Factors for Mortality Associated With Influenza Infection in Patients With Hematologic Malignancies: A Cross‐Sectional Descriptive Observational Study
Background and Aims: Cancer patients, especially those with hematologic malignancies (HMs), are considered among the most vulnerable groups at risk for severe outcomes from influenza infection. This study aimed to investigate influenza infection in patients with HMs and identify the risk factors associated with mortality. Methods: This cross‐sectional descriptive observational study included 90 patients with confirmed influenza infection and HMs. The data collected included demographic information, cancer type and status, influenza type, symptoms, laboratory and radiologic findings, length of hospital stay, ICU admissions, and mortality rate. The primary outcome was analysis endpoints included mortality risk factors based on ICU admission, death and type of malignancies. Results: The mean age of patients was 34.3 ± 26.7 years (median 34, range 2–91). Most had acute lymphoblastic leukemia (ALL, 45.6%), followed by acute myeloid leukemia (AML, 22.2%), lymphomas (14.4%), multiple myeloma (MM, 6.7%), chronic myelogenous leukemia (CML, 2.2%), and other malignancies (8.9%). Nearly half (49.3%) were in the maintenance phase of treatment, and 80% were infected with influenza A. Pleural effusion (22.2%) and ground‐glass opacities (17.8%) were the most common radiologic findings. ICU admission was significantly linked to older age ( p = 0.002), comorbidity ( p = 0.003), lower respiratory tract infection (LRTI) ( p = 0.02), muscle ache ( p = 0.03), and malignancies including MM, CML, and AML ( p = 0.02). Higher mortality was observed in patients with MM or AML ( p = 0.01), comorbidities ( p = 0.02), and LRTIs ( p = 0.04). Age‐adjusted analysis confirmed MM, LRTI, and comorbidity as potential strong predictors of mortality. Conclusion: ICU admission was significantly associated with older age, the presence of at least one comorbidity, LRTI, and body muscle aches. MM, CML, and AML were notably more associated with ICU admission. Patients diagnosed with MM and AML, those with at least one comorbidity, and those with LRTIs had a higher risk of mortality. The age‐adjusted analysis identified MM, LRTIs, and comorbidities as potential strong predictors of mortality in this cohort, requiring validation in larger studies.
- 25 July 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (8)
Open AccessRisk Factors for Mortality Associated With Influenza Infection in Patients With Hematologic Malignancies: A Cross‐Sectional Descriptive Observational Study
Background and Aims: Cancer patients, especially those with hematologic malignancies (HMs), are considered among the most vulnerable groups at risk for severe outcomes from influenza infection. This study aimed to investigate influenza infection in patients with HMs and identify the risk factors associated with mortality. Methods: This cross‐sectional descriptive observational study included 90 patients with confirmed influenza infection and HMs. The data collected included demographic information, cancer type and status, influenza type, symptoms, laboratory and radiologic findings, length of hospital stay, ICU admissions, and mortality rate. The primary outcome was analysis endpoints included mortality risk factors based on ICU admission, death and type of malignancies. Results: The mean age of patients was 34.3 ± 26.7 years (median 34, range 2–91). Most had acute lymphoblastic leukemia (ALL, 45.6%), followed by acute myeloid leukemia (AML, 22.2%), lymphomas (14.4%), multiple myeloma (MM, 6.7%), chronic myelogenous leukemia (CML, 2.2%), and other malignancies (8.9%). Nearly half (49.3%) were in the maintenance phase of treatment, and 80% were infected with influenza A. Pleural effusion (22.2%) and ground‐glass opacities (17.8%) were the most common radiologic findings. ICU admission was significantly linked to older age ( p = 0.002), comorbidity ( p = 0.003), lower respiratory tract infection (LRTI) ( p = 0.02), muscle ache ( p = 0.03), and malignancies including MM, CML, and AML ( p = 0.02). Higher mortality was observed in patients with MM or AML ( p = 0.01), comorbidities ( p = 0.02), and LRTIs ( p = 0.04). Age‐adjusted analysis confirmed MM, LRTI, and comorbidity as potential strong predictors of mortality. Conclusion: ICU admission was significantly associated with older age, the presence of at least one comorbidity, LRTI, and body muscle aches. MM, CML, and AML were notably more associated with ICU admission. Patients diagnosed with MM and AML, those with at least one comorbidity, and those with LRTIs had a higher risk of mortality. The age‐adjusted analysis identified MM, LRTIs, and comorbidities as potential strong predictors of mortality in this cohort, requiring validation in larger studies.
- Open Access
- 26 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Proactive recognition and early detection in communities through targeted HIV screening
Human Immunodeficiency Virus (HIV) remains a critical public health concern, and is a significant global health challenge, particularly in developing countries. Early HIV detection supports targeted interventions, and substantially reduce the HIV burden. In many resource-limited settings, early detection of HIV is hindered by stigma, limited access to testing, and low risk awareness. This study aims to enhance HIV screening in resource-limited settings by employing machine learning models to predict HIV risk using demographic and lifestyle variables. We analyzed data from 39,295 individuals in Shiraz, Iran, identifying key predictors, including drug injection, age, having a spouse with a history of HIV, occupation, and prison record. We trained and validated an Extreme Gradient Boosting (XGBoost) model using stratified five-fold cross-validation on the dataset. The XGBoost model achieved high accuracy (0.89; Confidence Interval (CI) 95% [0.88–0.89]), very-good discriminatory ability (Area Under the ROC Curve (AUC = 0.84 [0.83–0.84], with a fair-to-good agreement (Cohen’s Kappa of 0.51 [0.51–0.52]). Moreover, the performance of the proposed method (PREDICT-HIV) was consistent across test folds. Our findings align with previous studies, emphasizing the importance of socio-demographic and behavioral factors in HIV risk prediction. The model’s robustness suggests its potential for practical implementation, aiding early identification and intervention in high-risk groups. Future research should incorporate additional socioeconomic variables and validate the model in diverse populations to enhance global HIV prevention efforts. The web application, implemented using the Django framework, is freely available online for public access. PREDICT-HIV may support earlier identification and intervention in underserved populations, improving the efficiency of HIV screening programs.
- 26 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Open AccessProactive recognition and early detection in communities through targeted HIV screening
Human Immunodeficiency Virus (HIV) remains a critical public health concern, and is a significant global health challenge, particularly in developing countries. Early HIV detection supports targeted interventions, and substantially reduce the HIV burden. In many resource-limited settings, early detection of HIV is hindered by stigma, limited access to testing, and low risk awareness. This study aims to enhance HIV screening in resource-limited settings by employing machine learning models to predict HIV risk using demographic and lifestyle variables. We analyzed data from 39,295 individuals in Shiraz, Iran, identifying key predictors, including drug injection, age, having a spouse with a history of HIV, occupation, and prison record. We trained and validated an Extreme Gradient Boosting (XGBoost) model using stratified five-fold cross-validation on the dataset. The XGBoost model achieved high accuracy (0.89; Confidence Interval (CI) 95% [0.88–0.89]), very-good discriminatory ability (Area Under the ROC Curve (AUC = 0.84 [0.83–0.84], with a fair-to-good agreement (Cohen’s Kappa of 0.51 [0.51–0.52]). Moreover, the performance of the proposed method (PREDICT-HIV) was consistent across test folds. Our findings align with previous studies, emphasizing the importance of socio-demographic and behavioral factors in HIV risk prediction. The model’s robustness suggests its potential for practical implementation, aiding early identification and intervention in high-risk groups. Future research should incorporate additional socioeconomic variables and validate the model in diverse populations to enhance global HIV prevention efforts. The web application, implemented using the Django framework, is freely available online for public access. PREDICT-HIV may support earlier identification and intervention in underserved populations, improving the efficiency of HIV screening programs.
- Open Access
- 11 April 2025
- Published by Termedia Sp. z.o.o. in HIV & AIDS Review
- Vol. 24 (1) , 68-74
HIV visibility among people living with HIV in the central of Iran
Background: Human Immunodeficiency Virus (HIV) has had far-reaching consequences for humans as a socio-medical problem. This study aimed to estimate HIV visibility by different categories of social network and their relevant factors. Material and methods: This cross-sectional study was...
- 11 April 2025
- Published by Termedia Sp. z.o.o. in HIV & AIDS Review
- Vol. 24 (1) , 68-74
Open AccessHIV visibility among people living with HIV in the central of Iran
Background: Human Immunodeficiency Virus (HIV) has had far-reaching consequences for humans as a socio-medical problem. This study aimed to estimate HIV visibility by different categories of social network and their relevant factors. Material and methods: This cross-sectional study was...
- Open Access
- 23 July 2024
- Published by Springer Nature in Nutrition & Diabetes
- Vol. 14 (1) , 1-10
Adherence to Mediterranean dietary pattern and the risk of gestational diabetes mellitus: a systematic review and meta-analysis of observational studies
Background and aim: Gestational diabetes mellitus (GDM) is one of the most prevalent disorders occurring during pregnancy, which confers significant risk of short and long-term adverse outcomes in both mothers and offspring. Recently, more attention has been paid to the association of pre-pregnancy and early pregnancy healthy dietary patterns, such as Mediterranean dietary pattern with GDM. However, there is a lack of systematic review and meta-analysis summarizing findings in this regard. Hence, we sought to assess the association of MedDiet and GDM in observational studies by performing a systematic review and meta-analysis. Methods: A comprehensive systematic literature search of observational studies was conducted via PubMed, Scopus, and Google Scholar, up to August 2023. Studies were included in our review if they evaluated the association of MedDiet and GDM, following an observational study design. Results: Ten studies were included in this study. Combining effect sizes, we found that adherence to MedDiet was inversely associated with GDM risk (OR = 0.64; CI: 0.52–0.78); implying that higher adherence to the MedDiet could reduce the risk of GDM by about 36%. Stratification by the geographic area, Mediterranean countries, time of dietary assessment and study design, showed a consistent significant association between MedDiet and GDM. Conclusion: We conclude that adhering to diets resembling MedDiet, before or in early pregnancy, could be associated with lower risks or odds of GDM.
- 23 July 2024
- Published by Springer Nature in Nutrition & Diabetes
- Vol. 14 (1) , 1-10
Open AccessAdherence to Mediterranean dietary pattern and the risk of gestational diabetes mellitus: a systematic review and meta-analysis of observational studies
Background and aim: Gestational diabetes mellitus (GDM) is one of the most prevalent disorders occurring during pregnancy, which confers significant risk of short and long-term adverse outcomes in both mothers and offspring. Recently, more attention has been paid to the association of pre-pregnancy and early pregnancy healthy dietary patterns, such as Mediterranean dietary pattern with GDM. However, there is a lack of systematic review and meta-analysis summarizing findings in this regard. Hence, we sought to assess the association of MedDiet and GDM in observational studies by performing a systematic review and meta-analysis. Methods: A comprehensive systematic literature search of observational studies was conducted via PubMed, Scopus, and Google Scholar, up to August 2023. Studies were included in our review if they evaluated the association of MedDiet and GDM, following an observational study design. Results: Ten studies were included in this study. Combining effect sizes, we found that adherence to MedDiet was inversely associated with GDM risk (OR = 0.64; CI: 0.52–0.78); implying that higher adherence to the MedDiet could reduce the risk of GDM by about 36%. Stratification by the geographic area, Mediterranean countries, time of dietary assessment and study design, showed a consistent significant association between MedDiet and GDM. Conclusion: We conclude that adhering to diets resembling MedDiet, before or in early pregnancy, could be associated with lower risks or odds of GDM.
- Open Access
- 1 June 2024
- Published by Apex Publishing in Nursing and Midwifery Journal
- Vol. 22 (3) , 180-190
INVESTIGATING THE RELATIONSHIP BETWEEN KNOWLEDGE AND ATTITUDES OF MIDWIVES AND DOCTORS ON THE QUALITY OF SYNDROMIC DIAGNOSIS AND TREATMENT OF SEXUALLY TRANSMITTED INFECTION IN WOMEN REFERRING TO COMPREHENSIVE HEALTHCARE CENTERS IN ISFAHAN CITY IN 2019
Background& Aim: Sexually transmitted infections (STIs) are a significant global public health issue that impacts people's quality of life, and clinical follow-up of the patients is a crucial aspect of treatment management in the patients. Syndromic treatment may be effective and cost-efficient in improving the care of STI patients. This study aimed ...
- 1 June 2024
- Published by Apex Publishing in Nursing and Midwifery Journal
- Vol. 22 (3) , 180-190
Open AccessINVESTIGATING THE RELATIONSHIP BETWEEN KNOWLEDGE AND ATTITUDES OF MIDWIVES AND DOCTORS ON THE QUALITY OF SYNDROMIC DIAGNOSIS AND TREATMENT OF SEXUALLY TRANSMITTED INFECTION IN WOMEN REFERRING TO COMPREHENSIVE HEALTHCARE CENTERS IN ISFAHAN CITY IN 2019
Background& Aim: Sexually transmitted infections (STIs) are a significant global public health issue that impacts people's quality of life, and clinical follow-up of the patients is a crucial aspect of treatment management in the patients. Syndromic treatment may be effective and cost-efficient in improving the care of STI patients. This study aimed ...
- Open Access
- 1 April 2024
- Published by Apex Publishing in Journal of Research Development in Nursing and Midwifery
- Vol. 21 (1) , 16-19
The observance of midwives' rights from the perspective of midwives and related managers
Background: Mutual rights in the medical system have always been considered an important component of medical ethics. Observance of midwives' rights could affect the quality of their services. This study was conducted to determine the methods for improving the observance of midwives' rights from the perspective of midwives and related ...
- 1 April 2024
- Published by Apex Publishing in Journal of Research Development in Nursing and Midwifery
- Vol. 21 (1) , 16-19
Open AccessThe observance of midwives' rights from the perspective of midwives and related managers
Background: Mutual rights in the medical system have always been considered an important component of medical ethics. Observance of midwives' rights could affect the quality of their services. This study was conducted to determine the methods for improving the observance of midwives' rights from the perspective of midwives and related ...
- Open Access
- 1 April 2024
- Published by Medknow in International Journal of Preventive Medicine
- Vol. 15, 18
Association of Prior COVID-19 Infection with Risk of Breakthrough Infection Following Vaccination: A Cohort Study in Isfahan, Iran
Background: Many people worldwide have developed a combination of natural and vaccine-induced immunity to COVID-19. This study investigated whether exposure to SARS-CoV-2 before full vaccination promotes protection against a breakthrough infection. Methods: We studied a total of 2,902,545 people in the Isfahan COVID-19 Registry. All the participants had received two doses of either Sinopharm BIBP, ChAdOx1-nCoV-19, Gam-COVID-Vac, or BIV1-CovIran vaccines. A cohort study examined the association between prior COVID-19 infection and the risk of a breakthrough infection for each vaccine. Cohorts in each pair were matched by gender, age group, calendar week of the first dose, the interval between the first and second doses, and the proportion of healthcare workers. The probable virus variant for the previous infections was also considered. Each individual’s follow-up started 14 days after their second vaccine dose until either the end of the study censoring date, occurrence of a COVID-19 infection, or death. The breakthrough infection risk was compared between each cohort pair by using the hazard ratio (HR) and incidence rate ratio (IRR). Results: Total breakthrough HRs (95% confidence interval) (previously infected over infection-naïve matched cohort) were 0.36 (0.23–0.55), 0.35 (0.32–0.40), 0.37 (0.30–0.46), and 0.43 (0.32–0.56) for the BIV1-CovIran, Sinopharm BIBP, Gam-COVID-Vac, and ChAdOx1-nCoV-19 vaccine groups, respectively. The breakthrough infection IRRs were approximately similar to the total HRs mentioned above. Conclusion: Prior SARS-CoV-2 infection conferred additive immunity against breakthrough after vaccination, no matter which vaccine brand was injected. Such a result could guide health authorities to codify low-cost high-benefit vaccination protocols and protect the community’s well-being.
- 1 April 2024
- Published by Medknow in International Journal of Preventive Medicine
- Vol. 15, 18
Open AccessAssociation of Prior COVID-19 Infection with Risk of Breakthrough Infection Following Vaccination: A Cohort Study in Isfahan, Iran
Background: Many people worldwide have developed a combination of natural and vaccine-induced immunity to COVID-19. This study investigated whether exposure to SARS-CoV-2 before full vaccination promotes protection against a breakthrough infection. Methods: We studied a total of 2,902,545 people in the Isfahan COVID-19 Registry. All the participants had received two doses of either Sinopharm BIBP, ChAdOx1-nCoV-19, Gam-COVID-Vac, or BIV1-CovIran vaccines. A cohort study examined the association between prior COVID-19 infection and the risk of a breakthrough infection for each vaccine. Cohorts in each pair were matched by gender, age group, calendar week of the first dose, the interval between the first and second doses, and the proportion of healthcare workers. The probable virus variant for the previous infections was also considered. Each individual’s follow-up started 14 days after their second vaccine dose until either the end of the study censoring date, occurrence of a COVID-19 infection, or death. The breakthrough infection risk was compared between each cohort pair by using the hazard ratio (HR) and incidence rate ratio (IRR). Results: Total breakthrough HRs (95% confidence interval) (previously infected over infection-naïve matched cohort) were 0.36 (0.23–0.55), 0.35 (0.32–0.40), 0.37 (0.30–0.46), and 0.43 (0.32–0.56) for the BIV1-CovIran, Sinopharm BIBP, Gam-COVID-Vac, and ChAdOx1-nCoV-19 vaccine groups, respectively. The breakthrough infection IRRs were approximately similar to the total HRs mentioned above. Conclusion: Prior SARS-CoV-2 infection conferred additive immunity against breakthrough after vaccination, no matter which vaccine brand was injected. Such a result could guide health authorities to codify low-cost high-benefit vaccination protocols and protect the community’s well-being.
- 19 August 2023
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 79, 104947
Multiple sclerosis is associated with worse COVID-19 outcomes compared to the general population: A population-based study
- 19 August 2023
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 79, 104947
Multiple sclerosis is associated with worse COVID-19 outcomes compared to the general population: A population-based study